Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers.

🤖 Plain-English Summary

The treatment of patients with advanced gynecologic malignancies remains challenging. The adoption of targeted therapeutics for the treatment of gynecologic cancers has been gradual, but we have started to see the rapid employment of novel targeted agents into clinical trial development, leading to new treatment approvals.

🔑 Key Findings

• Advancements in genomics have led to recognition and development of individualized therapeutic targets.
• This article reviews the current trends in precision medicine for treatment of gynecologic cancers.
• With the identification of the molecular aberrations inherent to gynecologic malignancies, we have discovered targetable mutations.

🔗 Related Resources